BioMS Medical to present at BioContact 2007

    Toronto Stock Exchange Symbol: MS

    EDMONTON, Sept. 28 /CNW/ - BioMS Medical Corp. (TSX: MS), a leading
developer in the treatment of multiple sclerosis (MS), today announced that
Mr. Tony Hesby, Executive Vice President Corporate Affairs, will give a
corporate presentation at BioContact 2007 in Québec City.

    WHEN:  Wednesday 3rd October, 2007 at 2:30pm (EST)

    WHERE: Château Frontenac, Québec

    About BioMS Medical Corp.

    BioMS Medical is a biotechnology company engaged in the development and
commercialization of novel therapeutic technologies. BioMS Medical's lead
technology, MBP8298, is for the treatment of multiple sclerosis and is being
evaluated in two pivotal phase III clinical trials for secondary progressive
MS patients, MAESTRO-01 in Canada and Europe and MAESTRO-03 in the United
States. It additionally is being evaluated for relapsing remitting MS patients
in a Phase II trial in Europe entitled MINDSET-01. For further information
please visit our website at

    This news release may contain certain forward-looking statements that
reflect the current views and/or expectations of BioMS Medical with respect to
its performance, business and future events. Such statements are subject to a
number of risks, uncertainties and assumptions. Actual results and events may
vary significantly.

For further information:

For further information: Tony Hesby, Ryan Giese, Corporate
Communications, BioMS Medical Corp., (780) 413-7152, (780) 408-3040 (Fax),
E-mail:, Internet:; James Smith,
Investor Relations, Toronto and U.S., (416) 815-0700 ext. 229, (416) 815-0080
(Fax), E-mail:; Mr. Barry Mire, Investor Relations,
Quebec, Phone: (514) 939-3989, E-mail:

Organization Profile

Medwell Capital Corp.

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890